During the past decade, Dr. J L Rohatgi Memorial Eye Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Dr. J L Rohatgi Memorial Eye Hospital" are "Neovascular Age-related Macular Degeneration" (1 trials) and "Non Infectious Uveitis" (1 trials). Many other conditions were trialed in "Dr. J L Rohatgi Memorial Eye Hospital" in a lesser frequency.

Most popular intervention types in "Dr. J L Rohatgi Memorial Eye Hospital" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "DE-109 Intravitreal Injections" (1 trials), "LUBT010 (proposed ranibizumab biosimilar)" (1 trials), "Lucentis (ranibizumab)" (1 trials) and "Sham Procedure" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dr. J L Rohatgi Memorial Eye Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Dr. J L Rohatgi Memorial Eye Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Dr. J L Rohatgi Memorial Eye Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dr. J L Rohatgi Memorial Eye Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".